Blue Marble Biomaterials Creates Revenue Streams For Partners In $3.2 Trillion Chemical Industry

MISSOULA, Mont., March 6, 2017 /PRNewswire/ -- Blue Marble Biomaterials (Blue Marble), a specialty chemical manufacturer and technology provider, offers proprietary technology that enables partners to turn their plant-based waste streams into revenue streams. Blue Marble can then turn these low-value organic leftovers into thousands of dollars' worth of high-value biochemicals. A new SEC-qualified Regulation A+ offering now allows individuals to invest in the company.

The first zero-waste chemical biorefinery in the United States, Blue Marble mimics natural processes to convert organic waste produced by food manufacturers into natural, non-GMO chemicals. These eco-friendly biochemicals provide an alternative to the ever-present petroleum-based chemicals found in nearly all manufactured products.

"Food manufacturers have few options when it comes to disposing of their waste products," said Blue Marble Co-CEO Colby Underwood. "Typically, food manufacturing companies have to pay for disposal of their leftover byproducts like grape pulp. We can provide a model whereby not only are they reducing or eliminating the cost of disposal, they're actually turning that waste into revenue. In turn, we can convert it into $15,000 worth of natural biochemicals."

These biochemicals are then used by fragrance, flavoring and personal-care product manufacturers as cost-saving replacements for crude-oil-derived chemicals traditionally used in most manufactured products. This allows manufacturers to respond to increasing consumer demand for cleaner, more natural products.

"Blue Marble offers food manufacturers a compelling option," says Charlotte Allen, Ph.D., former Associate Director of research and development for Kraft Foods. "Botanically based ingredients on the marketplace today can be cost prohibitive to incorporate into most consumer products. At scale, Blue Marble products are cost effective and could enable companies to create offerings for all consumers."

Well positioned to tap into the $3.2 trillion chemical market, and coming on the heels of a new partnership with global food giant Welch's, Blue Marble is offering equity shares to the public through a Regulation A+ offering qualified by the Securities and Exchange Commission. The initial round is set at $1.5 million and shares are $1.25 each, with a minimum investment of $300. Interested individuals can view the offering circular and find out more about the offering at https://www.manhattanstreetcapital.com/blue-marble-biomaterials.

"Historically, investing in companies like Blue Marble has been a luxury available to only accredited or high-net-worth individuals," said Rod Turner, CEO of Manhattan Street Capital, a fundraising platform specializing in Regulation A+ offerings. "Now, even entry-level investors can take advantage of the opportunity to own shares in an innovative company that is leading the emerging biomaterials industry."

About Blue Marble Biomaterials

Blue Marble uses proprietary technologies to convert plant-based organic waste, such as used coffee grounds, wood chips, and tomato and grape pomace, into natural and non-GMO chemicals that replace chemicals derived from crude oil. www.bluemarblebio.com

AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. YOU MAY OBTAIN A COPY OF THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT FROM https://www.sec.gov/Archives/edgar/data/1462326/000114420417009889/v459701_253g2.htm

YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.

SOURCE Blue Marble Biomaterials

Related Links

http://www.bluemarblebio.com